The Cabinet Committee on Economic Affairs approved the continuation of the Prime Minister Street Vendor's AtmaNirbhar Nidhi (PM SVANidhi) scheme till December 2024.
Expert panel of the Drug Controller General of India (DCGI) has recommended granting emergency use authorisation for Corbevax for children in the 5 to 12 years age group.
The Reserve Bank of India has set the limit for Ways and Means Advances (WMA) for the Central Government for the first half of the financial year 2022-23 (April 2022 to September 2022) at Rs. 1,50,000 crore.